Impact of inhibitor of apoptosis proteins on immune modulation and inflammation

Immunology and Cell Biology

Volumn 95, Issue 3, 2017, Pages 236-243

  Sharma, Sachin ^a   Kaufmann, Thomas ^b   Biswas, Subhrajit ^a  

^a INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EMBELIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE;

ADAPTIVE IMMUNITY; CELL PLASTICITY; DEATH; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LIFE; NONHUMAN; REVIEW; ANIMAL; APOPTOSIS; IMMUNITY; IMMUNOLOGY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; HUMANS; IMMUNITY; IMMUNOMODULATION; INFLAMMATION; INHIBITOR OF APOPTOSIS PROTEINS; SIGNAL TRANSDUCTION;

EID: 84994671515     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2016.101     Document Type: Review

References (80)

1. Eroglu M, Derry WB. Yours neighbours matter-non-Autonomous control of apoptosis in development and disease. Cell Death Differ 2016; 23: 1110-1118.
2. Crook NE, Clem RJ, Miller LK. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J Virol 1993; 67: 2168-2174.
3. Wang D, Berglund A, Kenchappa RS, Forsyth PA, Mulé JJ, Etame AB. BIRC3 is a novel driver of therapeutic resistance in glioblastoma. Sci Rep 2016; 6: 21710.
4. Lopez J, John SW, Tenev T, Rautureau GJ, Hinds MG, Francalanci F et al. CARD-mediated autoinhibition of cIAP1's E3 ligase activity suppresses cell proliferation and migration. Mol Cell 2011; 42: 569-583.
5. Abd-Elrahman I, Deutsch V, Pick M, Kay S, Neuman T, Perlman R et al. Differential regulation of the apoptotic machinery during megakaryocyte differentiation and platelet production by inhibitor of apoptosis protein Livin. Cell Death Dis 2013; 4: e937.
6. Lecis D, De Cesare M, Perego P, Conti A, Corna E, Drago C et al. Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity. Cell Death Dis 2013; 4: e920.
7. Sun C, Cai M, Gunasekera AH, Meadows RP, Wang H, Chen J et al. NMR structure and mutagenesis of the inhibitor of apoptosis protein XIAP. Nature 1999; 401: 818-822.
8. Lin S-C, Huang Y, Lo Y-C, Lu M, Wu H. Crystal structure of the BIR1 domain of XIAP in two crystal forms. J Mol Biol 2007; 372: 847-854.
9. Liu Z, Sun C, Olejniczak ET, Meadows RP, Betz SF, Oost T et al. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature 2000; 408: 1004-1008.
10. Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J et al. correction: A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 2001; 411: 1081-1081.
11. Lu M, Lin SC, Huang Y, Kang YJ, Rich R, Lo Y-C et al. XIAP induces NFκB activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol Cell 2007; 26: 689-702.
12. Chai J, Shiozaki E, Srinivasula SM, Wu Q, Dataa P, Alnemri ES et al. Structural basis of caspase-7 inhibition by XIAP. Cell 2001; 104: 769-780.
13. Shiozaki EN, Chai J, Rigotti DJ, Riedl SJ, Li P, Srinivasula SM et al. Mechanism of XIAP-mediated inhibition of caspase-9. Mol Cell 2003; 11: 519-527.
14. Silke J, Ekert PG, Day CL, Hawkins CJ, Baca M, Chew J et al. Direct inhibition of caspase 3 is dispensable for the anti-Apoptotic activity of XIAP. EMBO J 2001; 20: 3114-3123.
15. Eckelman BP, Salvesen GS. The human anti-Apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem 2006; 281: 3254-3260.
16. Molofsky AB, Byrne BG, Whitfield NN, Madigan CA, Fuse ET, Tateda K et al. Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection. J Exp Med 2006; 203: 1093-1104.
17. Jeyaprakash AA, Klein UR, Lindner D, Ebert J, Nigg EA, Conti E. Structure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel together. Cell 2007; 131: 271-285.
18. Pohl C, Jentsch S. Final stages of cytokinesis and midbody ring formation are controlled by BRUCE. Cell 2008; 132: 832-845.
19. Richter BW, Mir SS, Eiben LJ, Lewis J, Reffey SB, Frattini A et al. Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family. Mol Cell Biol 2001; 21: 4292-4301.
20. Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS, Dixit VM. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol 2000; 10: 1359-1366.
21. Varfolomeev E, Goncharov T, Maecker H, Zobel K, Kmóves LG, Deshayes K et al. Cellular inhibitors of apoptosis are global regulators of NFκB and MAPK activation by members of the TNF family of receptors. Sci Signal 2012; 5: ra22-ra22.
22. Zou J, Shankar N. Roles of TLR/MyD88/MAPK/NFκB signaling pathways in the regulation of phagocytosis and proinflammatory cytokine expression in response to E. faecalis infection. PLoS ONE 2015; 10: e0136947.
23. Mahoney D, Cheung H, Mrad RL, Plenchette S, Simard C, Enwere E et al. Both cIAP1 and cIAP2 regulate TNFα-mediated NFκB activation. PNAS 2008; 105: 11778-11783.
24. Cildir G, Low KC, Tergaonkar V. Noncanonical NFκB signaling in health and disease. Trends Mol Med 2016; 22: 414-429.
25. Guijarro-Munoz I, Compte M, Alvarez-Cienfuegos A, Alvarez-Vallina L, Sanz L. Lipopolysaccharide activates Toll-like receptor 4 (TLR4)-mediated NF-kappaB signaling pathway and proinflammatory response in human pericytes. J Biol Chem 2014; 289: 2457-2468.
26. Dynek JN, Goncharov T, Dueber EC, Fedorova AV, Izrael-Tomasevic A, Phu L et al. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J 2010; 29: 4198-4209.
27. Chu Z-L, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NFκB control. PNAS 1997; 94: 10057-10062.
28. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J. NFκB signals induce the expression of c-FLIP. Mol Cell Biol 2001; 21: 5299-5305.
29. Zhao Y, Conze DB, Hanover JA, Ashwell JD. Tumor necrosis factor receptor 2 signaling induces selective c-IAP1-dependent ASK1 ubiquitination and terminates mitogen-Activated protein kinase signaling. J Biol Chem 2007; 282: 7777-7782.
30. Vince JE, Wong WW-L, Khan N, Feltham R, Chau D, Ahmed AU et al. IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis. Cell 2007; 131: 682-693.
31. Kimura N, Matsuo R, Shibuya H, Nakashima K, Taga T. BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J Biol Chem 2000; 275: 17647-17652.
32. Ting AT, Pimentel-Muiños FX, Seed B. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J 1996; 15: 6189-6196.
33. Moquin DM, McQuade T, Chan FK. CYLD deubiquitinates RIP1 in the TNFalphainduced necrosome to facilitate kinase activation and programmed necrosis. PLoS ONE 2013; 8: e76841.
34. Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang JG, Alvarez-Diaz S et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 2013; 39: 443-453.
35. de Koning HD, Rodijk-Olthuis D, van Vlijmen-Willems IMJJ, Joosten LAB, Netea MG, Schalkwijk J et al. A comprehensive analysis of pattern recognition receptors in normal and inflamed human epidermis: upregulation of dectin-1 in psoriasis. J Invest Dermatol 2010; 130: 2611-2620.
36. Leulier F, Lhocine N, Lemaitre B, Meier P. The Drosophila inhibitor of apoptosis protein DIAP2 functions in innate immunity and is essential to resist gram-negative bacterial infection. Mol Cell Biol 2006; 26: 7821-7831.
37. Damgaard RB, Nachbur U, Yabal M, Wong WW, Fiil BK, Kastirr M et al. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol Cell 2012; 46: 746-758.
38. Weber A, Kirejczyk Z, Besch R, Potthoff S, Leverkus M, Häcker G. Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells. Cell Death Differ 2010; 17: 942-951.
39. Hasegawa M, Fujimoto Y, Lucas PC, Nakano H, Fukase K, Niez G et al. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NFκB activation. EMBO J 2008; 27: 373-383.
40. Bertrand MJ, Doiron K, Labbé K, Korneluk RG, Barker PA, Saleh M. Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity 2009; 30: 789-801.
41. Krieg A, Correa RG, Garrison JB, Le Negrate G, Welsh K, Huang Z et al. XIAP mediates NOD signaling via interaction with RIP2. PNAS 2009; 106: 14524-14529.
42. Bauler LD, Duckett CS, O'Riordan M. XIAP regulates cytosol-specific innate immunity to Listeria infection. PLoS Pathog 2008; 4: e1000142-e1000142.
43. Prakash H, Albrecht M, Becker D, Kuhlmann T, Rudel T. Deficiency of XIAP leads to sensitization for Chlamydophila pneumoniae pulmonary infection and dysregulation of innate immune response in mice. J Biol Chem 2010; 285: 20291-20302.
44. Andree M, Seeger JM, Schöll S, Coutelle O, Wagner-Stippich D, Wiegmann K et al. BID-dependent release of mitochondrial SMAC dampens XIAP-mediated immunity against Shigella. EMBO J 2014; 33: 2171-2187.
45. Rigaud S, Fondaneche MC, Lambert N, Pasquier B, Mateo V, Soulas P et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006; 444: 110-114.
46. Zeissig Y, Petersen BS, Milutinovic S, Bosse E, Mayr G, Peuker K et al. XIAP variants in male Crohn's disease. Gut 2015; 64: 66-76.
47. Vince JE, Wong WW-L, Gentle I, Lawlor KE, Allam R, O'Reilly L et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 2012; 36: 215-227.
48. Chen I-T, Hsu P-H, Hsu W-C, Chen N-J, Tseng P-H. Polyubiquitination of transforming growth factor β-Activated kinase 1 (TAK1) at lysine 562 residue regulates TLR4-mediated JNK and p38 MAPK activation. Sci Rep 2015; 5: 12300.
49. Tseng P-H, Matsuzawa A, Zhang W, Mino T, Vignali DA, Karin M. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat Immunol 2010; 11: 70-75.
50. Chan YK, Gack MU. Viral evasion of intracellular DNA and RNA sensing. Nat Rev Micro 2016; 14: 360-373.
51. Mao A-P, Li S, Zhong B, Li Y, Yan J, Li Q et al. Virus-Triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-β (IFN-β) and cellular antiviral response. J Biol Chem 2010; 285: 9470-9476.
52. White CL, Chattopadhyay S, Sen GC. Phosphatidylinositol 3-kinase signaling delays Sendai virus-induced apoptosis by preventing XIAP degradation. J Virol 2011; 85: 5224-5227.
53. Liu S, Chen J, Cai X, Wu J, Chen X, Wu Y-T et al. MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. Elife 2013; 2: e00785.
54. Rodrigue-Gervais IG, Labbe K, Dagenais M, Dupaul-Chicoine J, Champagne C, Morizot A et al. Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during Influenza virus infection to promote host survival. Cell Host Microbe 2014; 15: 23-35.
55. Yang J, Zhao Y, Shi J, Shao F. Human NAIP and mouse NAIP1 recognize bacterial type III secretion needle protein for inflammasome activation. PNAS 2013; 110: 14408-14413.
56. Zamboni DS, Kobayashi KS, Kohlsdorf T, Ogura Y, Long EM, Vance RE et al. The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat Immunol 2006; 7: 318-325.
57. Labbé K, McIntire CR, Doiron K, Leblanc PM, Saleh M. Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome. Immunity 2011; 35: 897-907.
58. Guo H, Callaway JB, Ting JPY. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med 2015; 21: 677-687.
59. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D et al. Cutting edge: NFκB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009; 183: 787-791.
60. Kang T-B, Yang S-H, Toth B, Kovalenko A, Wallach D. Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity 2013; 38: 27-40.
61. Wu Y, Kuo W, Wu Y, Yang K, Chen S, Jiang S et al. Participation of c-FLIP in NLRP3 and AIM2 inflammasome activation. Cell Death Differ 2014; 21: 451-461.
62. Yabal M, Möller N, Adler H, Knies N, Groß CJ, Damgaard RB et al. XIAP restricts TNF-And RIP3-dependent cell death and inflammasome activation. Cell Rep 2014; 7: 1796-1808.
63. Zarnegar BJ, Wang Y, Mahoney DJ, Dempsey PW, Cheung HH, He J et al. Noncanonical NFκB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat Immunol 2008; 9: 1371-1378.
64. Dougan M, Dougan S, Slisz J, Firestone B, Vanneman M, Draganov D et al. IAP inhibitors enhance co-stimulation to promote tumor immunity. J Exp Med 2010; 207: 2195-2206.
65. Möller-Sienerth N, Dietz L, Holtz P, Kapp M, Grigoleit GU, Schmuck C et al. SMAC mimetic BV6 induces cell death in monocytes and maturation of monocyte-derived dendritic cells. PLoS ONE 2011; 6: e21556-e21556.
66. Kavanagh E, Rodhe J, Burguillos MA, Venero JL, Joseph B. Regulation of caspase-3 processing by cIAP2 controls the switch between pro-inflammatory activation and cell death in microglia. Cell Death Dis 2014; 5: e1565.
67. Marsh RA, Villanueva J, Kim M-O, Zhang K, Marmer D, Risma KA et al. Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations. Clin Immunol 2009; 132: 116-123.
68. Xing Z, Conway EM, Kang C, Winoto A. Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis. J Exp Med 2004; 199: 69-80.
69. Conte D, Holcik M, Lefebvre CA, LaCasse E, Picketts DJ, Wright KE et al. Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival. Mol Cell Biol 2006; 26: 699-708.
70. Dharmapatni AASSK, Cantley MD, Marino V, Perilli E, Crotti TN, Smith MD et al. The X-linked inhibitor of apoptosis protein inhibitor embelin suppresses inflammation and bone erosion in collagen antibody induced arthritis mice. Mediators Inflamm 2015; 2015: 564042.
71. Hornburger MC, Mayer BA, Leonhardt S, Willer EA, Zahler S, Beyerle A et al. A novel role for inhibitor of apoptosis (IAP) proteins as regulators of endothelial barrier function by mediating RhoA activation. FASEB J 2014; 28: 1938-1946.
72. Nikolovska-Coleska Z, Xu L, Hu Z, Tomita Y, Li P, Roller PP et al. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J Med Chem 2004; 47: 2430-2440.
73. Mayer BA, Rehberg M, Erhardt A, Wolf A, Reichel CA, Kracht M et al. Inhibitor of apoptosis proteins as novel targets in inflammatory processes. Arterioscler Thromb Vasc Biol 2011; 31: 2240-2250.
74. Bai L, Smith DC, Wang S. Small-molecule SMAC mimetics as new cancer therapeutics. Pharmacol Ther 2014; 144: 82-95.
75. Tao Z, Myers C, Wiedemann N, Vuagniaux G, Harshyne L, Dicker A et al. Smac mimetic and radiotherapy synergize to enhance antitumor immunity in lung cancer by targeting immunosuppressive cells. Cancer Res 2015; 75(Suppl 15): Abstract283.
76. Rettinger E, Glatthaar A, Abhari BA, Oelsner S, Pfirrmann V, Huenecke S et al. SMAC mimetic BV6 enables sensitization of resistant tumor cells but also affects cytokine-induced killer (CIK) cells: A potential challenge for combination therapy. Front Pediatr 2014; 2: 75.
77. Noonan AM, Bunch KP, Chen JQ, Herrmann MA, Lee JM, Kohn EC et al. Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or-refractory epithelial ovarian cancer. Cancer 2016; 122: 588-597.
78. Yang Y, Kelly P, Shaffer AL 3rd, Schmitz R, Yoo HM, Liu X et al. Targeting nonproteolytic protein ubiquitination for the treatment of diffuse large B cell lymphoma. Cancer cell 2016; 29: 494-507.
79. Ebert G, Preston S, Allison C, Cooney J, Toe JG, Stutz MD et al. Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus. PNAS 2015; 112: 5797-5802.
80. Ebert G, Allison C, Preston S, Cooney J, Toe JG, Stutz MD et al. Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis. PNAS 2015; 112: 5803-5808